STAT3 and acute lymphoblastic leukemia: With 2.5 × 106 STAT3–/– T cells added to the graft, the ALL cells were eliminated in approximately 50% of recipients, but all the recipients given 1.0 × 106 STAT3–/– T cells had progressive tumor growth (Figure 2, C and D).